Sumadan
Pricing Report NDC 43538-191-16
Current Package Pricing Information
The latest wholesale acquisition cost for Sumadan (NDC 43538-191-16) is $803.84862 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 31, 2020.
As a provided by Medimetriks Pharmaceuticals Inc., this medication is distributed in a 1 KIT in 1 CARTON * 1 BOTTLE, PUMP in 1 CARTON / 454 g in 1 BOTTLE, PUMP * 1 BOTTLE, PUMP in 1 CARTON / 454 g in 1 BOTTLE, PUMP configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $803.84862 Per EA
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Historical Pricing Trends & Acquisition Cost Benchmarks
Since Oct 2013, the NADAC wholesale price for (NDC ) has moved within a range of $286.15191 to $803.84862 per EA. Over this 6 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
$286.1519 - $803.8486
180.92% Variance
5.57%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Jul 31, 2020 | $803.84862 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Jul 31, 2020 | $803.84862 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Sep 19, 2019 | $761.40054 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Sep 19, 2019 | $761.40054 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jun 28, 2019 | $698.52619 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Jun 28, 2019 | $698.52619 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Mar 01, 2019 | $662.32987 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Mar 01, 2019 | $662.32987 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Aug 31, 2018 | $633.39026 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Aug 31, 2018 | $633.39026 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Dec 29, 2017 | $616.43821 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Dec 29, 2017 | $616.43821 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| May 09, 2017 | $587.90148 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| May 09, 2017 | $587.90148 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Mar 31, 2017 | $573.55682 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Mar 31, 2017 | $573.55682 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Apr 04, 2016 | $544.17672 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Apr 04, 2016 | $544.17672 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jan 01, 2016 | $525.27217 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Jan 01, 2016 | $525.27217 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jul 21, 2015 | $480.72352 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Jul 21, 2015 | $480.72352 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| May 26, 2015 | $433.00624 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| May 26, 2015 | $433.00624 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jan 26, 2015 | $383.98311 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Jan 26, 2015 | $383.98311 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Dec 20, 2014 | $356.36814 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Dec 20, 2014 | $356.36814 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| May 01, 2014 | $329.45192 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| May 01, 2014 | $329.45192 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Mar 25, 2014 | $319.50881 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Mar 25, 2014 | $319.50881 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Dec 24, 2013 | $311.23312 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B - Brand |
| Dec 24, 2013 | $311.23312 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Oct 01, 2013 | $286.15191 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
Pricing Methodology Legend
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
- Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
